|
Background |
Histone
modifications, such as acetylation and methylation, are
important epigenetic marks that regulate diverse biological
processes that use chromatin as the template, including
transcription. Dysregulation of histone acetylation and
methylation leads to the silencing of tumor suppressor genes and
contributes to cancer progression. Inhibitors of enzymes that
catalyze the addition and removal of these epigenetic marks thus
have therapeutic potential for treating cancer. Lysine-specific
demethylase 1 (LSD1) is the first discovered histone lysine
demethylase and, with the help of its cofactor CoREST,
specifically demethylates mono- and dimethylated histone H3
lysine 4 (H3-K4), thus repressing transcription. |
|
Synonyms |
COREST,
KIAA0071, RCOR, protein CoREST, REST corepressor, REST
corepressor |
|
Reference |
Yang,
M., Culhane, J.C., Szewczuk, L.M., Jalili, P., Ball,
H.L., Machius, M., Cole, P.A., Yu, H.Structural Basis for the
Inhibition of the Lsd1 Histone Demethylase by the Antidepressant
Trans-2-Phenylcyclopropylamine.Biochemistry, 2007,46: 8058-8065 |